Annual Drug Patent Expirations for AYVAKIT
Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has forty patent family members in thirty-one countries.
The generic ingredient in AYVAKIT is avapritinib. One supplier is listed for this compound. Additional details are available on the avapritinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
